Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heart of darkness: the downside of trastuzumab.

× No keyword cloud information.

9 in total

Review 1. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors: Balazs I Bodai; Phillip Tuso
Journal: Perm J Date: 2015

Review 2. Applying the New Guidelines of HER2 Testing in Breast Cancer.

Authors: Huina Zhang; Ioana Moisini; Rana M Ajabnoor; Bradley M Turner; David G Hicks
Journal: Curr Oncol Rep Date: 2020-04-29 Impact factor: 5.075

Review 3. The adjuvant treatment of HER2-positive breast cancer.

Authors: Danijela Jelovac; Antonio C Wolff
Journal: Curr Treat Options Oncol Date: 2012-06

4. First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.

Authors: Ya-Chen Tina Shih; Ying Xu; Wenli Dong; Fabrice Smieliauskas; Sharon Giordano; Yu Shen
Journal: Breast Cancer Res Treat Date: 2014-02-21 Impact factor: 4.872

Review 5. Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors: Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal: Circulation Date: 2016-03-15 Impact factor: 29.690

Review 6. Cardiac toxicity of anticancer agents.

Authors: Alessandro Colombo; Carlo Cipolla; Marta Beggiato; Daniela Cardinale
Journal: Curr Cardiol Rep Date: 2013-05 Impact factor: 2.931

7. HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma.

Authors: Kourosh Movagharnejad; Majid Sharbatdaran; Shahryar Sheffaee; Mehrdad Kashifard; Sadegh Sedaghat
Journal: Int J Mol Cell Med Date: 2013

8. Near-infrared quantum dots for HER2 localization and imaging of cancer cells.

Authors: Sarwat B Rizvi; Sepideh Rouhi; Shohei Taniguchi; Shi Yu Yang; Mark Green; Mo Keshtgar; Alexander M Seifalian
Journal: Int J Nanomedicine Date: 2014-03-11

9. In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients.

Authors: Maria Vassilakopoulou; Taiwo Togun; Urania Dafni; Huan Cheng; Jennifer Bordeaux; Veronique M Neumeister; Mattheos Bobos; George Pentheroudakis; Dimosthenis V Skarlos; Dimitrios Pectasides; Vassiliki Kotoula; George Fountzilas; David L Rimm; Amanda Psyrri
Journal: PLoS One Date: 2014-06-26 Impact factor: 3.240

9 in total